KEVIN YOUNG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN YOUNG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN YOUNG. KEVIN YOUNG is Chief Operating Officer in GILEAD SCIENCES INC ($GILD) and EVP, Commercial Operations in GILEAD SCIENCES INC ($GILD) and Director in Cortexyme, Inc. ($CRTX).
Latest Insider Trading Transactions of KEVIN YOUNG
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.64 | 1,000 | 41,640 | 8,681 | 9.7 K to 8.7 K (-10.33 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.62 | 2,000 | 83,240 | 9,681 | 11.7 K to 9.7 K (-17.12 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.51 | 500 | 20,755 | 11,681 | 12.2 K to 11.7 K (-4.10 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.59 | 3,000 | 124,770 | 12,181 | 15.2 K to 12.2 K (-19.76 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.65 | 2,500 | 104,125 | 15,181 | 17.7 K to 15.2 K (-14.14 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.66 | 500 | 20,830 | 17,681 | 18.2 K to 17.7 K (-2.75 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.55 | 1,000 | 41,550 | 18,181 | 19.2 K to 18.2 K (-5.21 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.60 | 5,500 | 228,800 | 19,181 | 24.7 K to 19.2 K (-22.28 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.58 | 3,500 | 145,530 | 24,681 | 28.2 K to 24.7 K (-12.42 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.46 | 1,000 | 41,460 | 28,181 | 29.2 K to 28.2 K (-3.43 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.53 | 1,000 | 41,530 | 29,181 | 30.2 K to 29.2 K (-3.31 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.50 | 2,000 | 83,000 | 30,181 | 32.2 K to 30.2 K (-6.21 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.49 | 500 | 20,745 | 32,181 | 32.7 K to 32.2 K (-1.53 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 41.43 | 2,000 | 82,860 | 32,681 | 34.7 K to 32.7 K (-5.77 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 17.68 | 20,000 | 353,500 | 34,681 | 14.7 K to 34.7 K (+136.23 %) |
| Oct 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 16.01 | 10,000 | 160,100 | 14,681 | 4.7 K to 14.7 K (+213.63 %) |
| Jul 06 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 17.68 | 20,000 | 353,500 | 293,790 | |
| Jul 06 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 16.01 | 10,000 | 160,100 | 139,340 | |
| Jul 06 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 39.36 | 30,000 | 1,180,854 | 4,681 | 34.7 K to 4.7 K (-86.50 %) |
| Jul 06 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 17.68 | 20,000 | 353,500 | 34,681 | 14.7 K to 34.7 K (+136.23 %) |
| Jul 06 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 16.01 | 10,000 | 160,100 | 14,681 | 4.7 K to 14.7 K (+213.63 %) |
| May 10 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 82.96 | 35,000 | 2,903,600 | 35,000 | |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 35.35 | 20,000 | 707,000 | 156,895 | |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 32.02 | 10,000 | 320,200 | 74,670 | |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.33 | 2,800 | 202,524 | 1,974 | 4.8 K to 2 K (-58.65 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.36 | 100 | 7,236 | 4,774 | 4.9 K to 4.8 K (-2.05 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.28 | 2,400 | 173,472 | 4,874 | 7.3 K to 4.9 K (-32.99 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.34 | 5,591 | 404,453 | 7,274 | 12.9 K to 7.3 K (-43.46 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.32 | 1,668 | 120,630 | 12,865 | 14.5 K to 12.9 K (-11.48 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.37 | 1,580 | 114,345 | 14,533 | 16.1 K to 14.5 K (-9.81 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.26 | 1,000 | 72,260 | 16,113 | 17.1 K to 16.1 K (-5.84 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.27 | 234 | 16,911 | 17,113 | 17.3 K to 17.1 K (-1.35 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.31 | 500 | 36,155 | 17,347 | 17.8 K to 17.3 K (-2.80 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.29 | 1,100 | 79,519 | 17,847 | 18.9 K to 17.8 K (-5.81 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.30 | 400 | 28,920 | 18,947 | 19.3 K to 18.9 K (-2.07 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.23 | 731 | 52,800 | 19,347 | 20.1 K to 19.3 K (-3.64 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.25 | 1,728 | 124,848 | 20,078 | 21.8 K to 20.1 K (-7.92 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 72.24 | 10,168 | 734,536 | 21,806 | 32 K to 21.8 K (-31.80 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 35.35 | 20,000 | 707,000 | 31,974 | 12 K to 32 K (+167.03 %) |
| Feb 22 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 32.02 | 10,000 | 320,200 | 11,974 | 2 K to 12 K (+506.59 %) |
| Jan 24 2007 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 65.58 | 130,000 | 8,525,400 | 130,000 | |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 32.02 | 24,000 | 768,480 | 84,670 | |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.06 | 2,264 | 140,504 | 1,254 | 3.5 K to 1.3 K (-64.35 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.05 | 1,400 | 86,870 | 3,518 | 4.9 K to 3.5 K (-28.47 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.04 | 4,006 | 248,532 | 4,918 | 8.9 K to 4.9 K (-44.89 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.03 | 400 | 24,812 | 8,924 | 9.3 K to 8.9 K (-4.29 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.02 | 3,162 | 196,107 | 9,324 | 12.5 K to 9.3 K (-25.32 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.01 | 900 | 55,809 | 12,486 | 13.4 K to 12.5 K (-6.72 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 62.00 | 11,868 | 735,816 | 13,386 | 25.3 K to 13.4 K (-46.99 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 32.02 | 24,000 | 768,480 | 25,254 | 1.3 K to 25.3 K (+1,913.88 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 35.35 | 11,793 | 416,883 | 176,895 | |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 32.02 | 13,207 | 422,888 | 108,670 | |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.16 | 10,500 | 642,180 | 1,254 | 11.8 K to 1.3 K (-89.33 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.19 | 200 | 12,238 | 11,754 | 12 K to 11.8 K (-1.67 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.20 | 400 | 24,480 | 11,954 | 12.4 K to 12 K (-3.24 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.18 | 1,800 | 110,124 | 12,354 | 14.2 K to 12.4 K (-12.72 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.21 | 3,200 | 195,872 | 14,154 | 17.4 K to 14.2 K (-18.44 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.22 | 100 | 6,122 | 17,354 | 17.5 K to 17.4 K (-0.57 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.24 | 5,600 | 342,944 | 17,454 | 23.1 K to 17.5 K (-24.29 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.25 | 500 | 30,625 | 23,054 | 23.6 K to 23.1 K (-2.12 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.26 | 2,200 | 134,772 | 23,554 | 25.8 K to 23.6 K (-8.54 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.23 | 500 | 30,615 | 25,754 | 26.3 K to 25.8 K (-1.90 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 35.35 | 11,793 | 416,883 | 26,254 | 14.5 K to 26.3 K (+81.55 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Buy | M | 32.02 | 13,207 | 422,888 | 14,661 | 1.5 K to 14.7 K (+908.32 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 35.35 | 47,172 | 1,667,530 | 188,688 | |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 35.35 | 2,828 | 99,970 | 11,312 | |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.35 | 17,890 | 1,079,662 | 1,254 | 19.1 K to 1.3 K (-93.45 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.36 | 100 | 6,036 | 19,144 | 19.2 K to 19.1 K (-0.52 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.37 | 4,000 | 241,480 | 19,244 | 23.2 K to 19.2 K (-17.21 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.38 | 400 | 24,152 | 23,244 | 23.6 K to 23.2 K (-1.69 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.39 | 300 | 18,117 | 23,644 | 23.9 K to 23.6 K (-1.25 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.40 | 700 | 42,280 | 23,944 | 24.6 K to 23.9 K (-2.84 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.41 | 100 | 6,041 | 24,644 | 24.7 K to 24.6 K (-0.40 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.42 | 4,100 | 247,722 | 24,744 | 28.8 K to 24.7 K (-14.21 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.43 | 300 | 18,129 | 28,844 | 29.1 K to 28.8 K (-1.03 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.46 | 100 | 6,046 | 29,144 | 29.2 K to 29.1 K (-0.34 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.47 | 900 | 54,423 | 29,244 | 30.1 K to 29.2 K (-2.99 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 60.50 | 21,110 | 1,277,155 | 30,144 | 51.3 K to 30.1 K (-41.19 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Grant | A | 35.35 | 47,172 | 1,667,530 | 51,254 | 4.1 K to 51.3 K (+1,155.61 %) |
| Feb 03 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Grant | A | 35.35 | 2,828 | 99,970 | 4,082 | 1.3 K to 4.1 K (+225.52 %) |
| Jan 27 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 58.01 | 180,000 | 10,441,800 | 180,000 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 32.02 | 121,877 | 3,902,502 | 121,877 | |
| Jan 28 2005 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 32.02 | 3,123 | 99,998 | 3,123 | |
| Nov 04 2004 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 35.35 | 235,860 | 8,337,651 | 235,860 | |
| Nov 04 2004 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 35.35 | 14,140 | 499,849 | 14,140 |